NASDAQ:IDXG

Interpace Diagnostics Group Stock Forecast

etoro logo Buy IDXG
*Your capital is at risk
$1.75
-0.0100 (-0.568%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of IDXG AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IDXG to Watchlist?
Some Reasons Why To Add IDXG:
  • +124.4% price growth over the last year
  • Healthy interest coverage ratio of 37.5x
  • Strong return on equity of 215.3%
PDF

Interpace Diagnostics Group stock upgraded from Sell Candidate to Hold/Accumulate after Wednesday trading session
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jun 03, 2026

The Interpace Diagnostics Group stock price fell by -0.568% on the last day (Wednesday, 3rd Jun 2026) from $1.76 to $1.75. During the last trading day the stock fluctuated 2.94% from a day low at $1.70 to a day high of $1.75. The price has been going up and down for this period, and there has been a -2.78% loss for the last 2 weeks. Volume has increased on the last day by 239 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 thousand shares were bought and sold for approximately $2.71 thousand.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.70 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.42% during the next 3 months and, with a 90% probability hold a price between $1.78 and $2.46 at the end of this 3-month period.

IDXG Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, May 29, 2026, and so far it has risen 2.94%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Interpace Diagnostics Group stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.76 and $1.92. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Interpace Diagnostics Group gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Interpace Diagnostics Group stock

Interpace Diagnostics Group finds support from accumulated volume at $1.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0500 between high and low, or 2.94%. For the last week, the stock has had daily average volatility of 1.92%.

Our recommended stop-loss: $1.67 (-4.38%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (IDXG) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Interpace Diagnostics Group to open at $1.73, and during the day (based on 14 day Average True Range), to move between $1.71 and $1.79, which gives a possible trading interval of +/-$0.0790 (+/-4.62%) up or down from last closing price. If Interpace Diagnostics Group takes out the full calculated possible swing range there will be an estimated 4.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.73 (1.14%) than the resistance at $1.80 (2.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Interpace Diagnostics Group stock A Buy?

Interpace Diagnostics Group holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.615 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $1.73 ( 0.95%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IDXG Performance

Trading levels for IDXG

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.78 1.90%
R2 1.76 0.81%
R1 1.75 0.139%
Price 1.75
S1 1.71 -2.04%
S2 1.70 -2.72%
S3 1.68 -3.81%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.13 21.71%
R2 1.89 8.00%
R1 1.80 2.86%
Price 1.75
S1 1.73 -1.14%
S2 1.72 -1.71%
S3 1.66 -5.14%

FAQ

What is the symbol for Interpace Diagnostics Group Stock and on which exchange is it traded?
The symbol for Interpace Diagnostics Group is IDXG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Interpace Diagnostics Group Stock?
Interpace Diagnostics Group holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Interpace Diagnostics Group Stock?
Interpace Diagnostics Group Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Interpace Diagnostics Group Stock.

What's the current price of Interpace Diagnostics Group Stock?
As of the end of day on the Jun 03, 2026, the price of an Interpace Diagnostics Group (IDXG) share was $1.75.

What is the 52-week high and low for Interpace Diagnostics Group Stock?
The 52-week high for Interpace Diagnostics Group Stock is $2.40 and the 52-week low is $0.700.

What is the market capitalization of Interpace Diagnostics Group Stock?
As of the Jun 03, 2026, the market capitalization of Interpace Diagnostics Group is 48.477M.

When is the next earnings date for Interpace Diagnostics Group?
The upcoming earnings date for Interpace Diagnostics Group is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT INTERPACE DIAGNOSTICS GROUP
Interpace Diagnostics Group
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited n...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE